Literature DB >> 10320717

Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats.

M Remmers1, R Schmidt-Kastner, L Belayev, B Lin, R Busto, M D Ginsberg.   

Abstract

Treatment with human albumin administered intravenously in the immediate post-ischemic period following a 2-h period of transient focal cerebral ischemia leads to a reduction of cortical infarction in rat. Immunohistochemistry with antibodies to rat immunoglobulins (IgG), rat albumin and (exogenous) human albumin was used to study blood-brain barrier changes. The degree of IgG extravasation was not changed by human-albumin treatment. Diffuse signals and uptake into necrotic neurons was seen in cortex of saline animals. In animals treated with human albumin, cortical neurons with preserved structural features had taken up human albumin. Treatment with human albumin may provide direct neuronal protection. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320717     DOI: 10.1016/s0006-8993(99)01304-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling.

Authors:  Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2006-08-01       Impact factor: 5.046

Review 2.  Synaptic signaling by lipids in the life and death of neurons.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 3.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

4.  Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.

Authors:  Seung Kyoon Woo; Min Seong Kwon; Zhihua Geng; Zheng Chen; Alexander Ivanov; Sergei Bhatta; Volodymyr Gerzanich; J Marc Simard
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

5.  Repeated Oral Administration of Human Serum Albumin Protects from the Cerebral Ischemia in Rat Brain Following MCAO.

Authors:  Hyejin Park; Minyoung Hong; Gil-Ja Jhon; Youngmi Lee; Minah Suh
Journal:  Exp Neurobiol       Date:  2017-06-16       Impact factor: 3.261

6.  Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid.

Authors:  Frankis G Almaguel; Jo-Wen Liu; Fabio J Pacheco; Carlos A Casiano; Marino De Leon
Journal:  J Neurosci Res       Date:  2009-04       Impact factor: 4.164

7.  Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia.

Authors:  Guang Jin; Ken Arai; Yoshihiro Murata; Sophia Wang; Monique F Stins; Eng H Lo; Klaus van Leyen
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

8.  Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.

Authors:  J Marc Simard; Vladimir Yurovsky; Natalia Tsymbalyuk; Ludmila Melnichenko; Svetlana Ivanova; Volodymyr Gerzanich
Journal:  Stroke       Date:  2008-11-20       Impact factor: 7.914

9.  Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.

Authors:  Li-Juan Zhang; Yue-Qiang Xue; Chun Yang; Wei-Hua Yang; Long Chen; Qian-Jin Zhang; Ting-Yu Qu; Shile Huang; Li-Ru Zhao; Xiao-Min Wang; Wei-Ming Duan
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window.

Authors:  Tiffany N Eady; Larissa Khoutorova; Kristal D Atkins; Nicolas G Bazan; Ludmila Belayev
Journal:  Exp Transl Stroke Med       Date:  2012-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.